Warning letter
Quick-Fill Mobile Oxygen, Inc.: warning letter of Dec 8, 2006
FDA warning letter UCM076202 · New Orleans District Office
Key facts
| Reference number | UCM076202 |
|---|---|
| Company | Quick-Fill Mobile Oxygen, Inc. |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Dec 8, 2006 |
| Posted date | Dec 8, 2006 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 211.188, 211.192, 211.22(a), 211.25(a), 211.100(a), 211.68(a), 211.160(b)(4) |
| Country | 3 |
| Inspection city | Hammond |
| Inspection ZIP | 70403-0324 |
| Inspection start date | Aug 14, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: